; and (B) the known characteristics of such treatment. (3) The treatment otherwise required under the protocol will cause or is likely to cause an adverse reaction or other physical harm to the participant or beneficiary. (4) The treatment otherwise required under the protocol is not in the best interest of the participant or beneficiary, based on medical necessity, because the participant or beneficiary’s use of such treatment is expected to decrease the participant or beneficiary’s ability— (A) to achieve or maintain reasonable and safe functional ability in performing daily activities or occupational responsibilities; or (B) to adhere to the treatment plan as defined by the prescribing health care provider. (5) The participant or beneficiary is stable for his or her disease or condition on the prescription drug or drugs selected by the prescribing health care provider. (c) Clear process The process required by subsection (a)(1)— (1) shall make information regarding such process readily available on the website of the group health plan, including— (A) the requirements for requesting an exception to a medication step therapy protocol pursuant to this section; and (B) any necessary forms, supporting information, and contact information